- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01429636
Applied Relaxation (AR) Technique Versus Its Modified Version for Treating Menopausal Symptoms
Phase 3 Study of Applied Relaxation (AR) Technique That Treating Menopausal Symptoms
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Applied Relaxation (AR) is the most commonly used behavioral methods for treating menopausal symptoms. Many clinical trials reported that the technique effectively improved vasomotor and related symptoms. There is a strong evidence to support its continue use in clinical settings.
However, the original AR technique is too cumbersome. It involves intensive training once a week for 12 consecutive weeks. Each weekly session takes 60 minutes, and subjects are requested to do self-practice at home for at least 15-20 minutes/day. As such, >25% of recruited subjects drop out from the training course. The investigators have modified the original AR technique by reducing the duration of training to only once, lasting 60 minutes. Participants are requested to do self-practice at home for 15-20 minutes/day as in the original technique. Instead of coming to a weekly class, the investigators use telephone to communicate with the subjects once a week for 12 consecutive weeks. A preliminary study showed all 10 recruited subjects remained in the study (MR; modified relaxation technique) until completion. They all reported dramatic improvement in their vasomotor symptoms.
In this study, the investigators propose to compare our modified version of AR with the original method in a randomized controlled clinical trial. The subjects will be Thai menopausal women with vasomotor symptoms. The main outcomes are the reduction in the MRS score (intensity of hot flushes, night sweats and sleep disturbances) among those who remain in the program at the end of the study (efficacy evaluation). As nearly all patients will remain in the MR group, while >25% of those in the AR group will be expected to drop out from the study, the investigators should be able to demonstrate a superiority of MR over AR in terms of effectiveness as well.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Northeast
-
Maha Sarakam, Northeast, Thailand, 44000
- Mahassarakham Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Perimenopausal women and postmenopausal women with either surgical or spontaneous menopause.
- Women who have at least 5 points of MRS score.
Exclusion Criteria:
- Women who are taking any hormone therapy for any reason in the past three months prior to entering the trails.
- Women with uncontrolled hypertension (>95mmHg diastolic pressure) or daily use of sedatives, tranquilizer or antidepressant medication.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Applied Relaxation (AR)
|
Participants will receive 12 sessions AR training.
After that they will asked to practice at home once a day for 15-20 minutes during their leisure times, at least 5 days a week for the whole 12 weeks of the follow-up period.
Other Names:
|
Experimental: Modified Relaxation (MR)
|
The MR technique is modified from the AR technique that will require participants to attend only 1 session, lasting 60 minutes.
After the training session, participants will be given a hand-out on MR.
They will continue to practice MR at home once a day for 15-20 minutes during their leisure times, at least 5 days a week for the whole 12 weeks of the follow-up period.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in global scores of Menopausal Rating Scale (MRS).
Time Frame: 12 weeks
|
MRS measure after intervention at 1, 2 and 3 months for follow-up.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the frequency and severity of hot flushes.
Time Frame: 12 weeks
|
Measure the frequency and severity of hot flushes after intervention at 1, 2 and 3 months.
|
12 weeks
|
Change in the frequency and severity of night sweats.
Time Frame: 12 weeks
|
Measure the frequency and severity of night sweats after intervention at 1, 2, and 3 months.
|
12 weeks
|
Change in the frequency and severity of sleep disturbances.
Time Frame: 12 weeks
|
Measure the frequency and severity of sleep disturbances after intervention at 1, 2, and 3 months.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Suprawita - Saensak, PhDcandidate, PhD in Clinical Epidemiology Program, Faculty of Medicine, Chiang Mai University (Thailand)
Publications and helpful links
Helpful Links
- NIH is the nation's medical research agency-supporting scientific studies that turn discovery into health.
- PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books.
- Elsevier is committed to making genuine contributions to the science and health communities.
- The Journal of The North American Menopause Society is a peer-reviewed scientific journal owned by NAMS and published by Lippincott Williams & Wilkins (LWW).
- The International Journal of Clinical and Health Psychology.
- The world's largest collection of STM books, journals, protocol and reference works.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ARMR-Sympts
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hot Flashes
-
Mitsubishi Tanabe Pharma America Inc.CompletedMenopause Hot FlashesUnited States
-
University of California, San FranciscoCompleted
-
University of California, San FranciscoCompleted
-
AmgenCompleted
-
Alison Huang, MDNational Institute on Aging (NIA)Completed
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedTreatment of Menopausal Hot FlashesUnited States
-
Donesta BioscienceSynteractHCRCompleted
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)CompletedHot Flashes | Hot FlushesUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedFever, Sweats, and Hot FlashesUnited States
-
University of PennsylvaniaForest LaboratoriesCompleted
Clinical Trials on Applied Relaxation (AR)
-
San Diego State UniversityNational Institute of Mental Health (NIMH)Completed
-
Elizabeth NedstrandTerminated
-
Technische Universität DresdenCompletedDepressive Disorder | Anxiety Disorders | Stress DisorderGermany
-
Mats HammarLinkoeping UniversityTerminated
-
University of Puerto RicoNational Institute of Mental Health (NIMH)CompletedPosttraumatic Stress DisorderPuerto Rico
-
German Research FoundationCompleted
-
Uppsala UniversityNot yet recruitingMultiple Sclerosis | InsomniaSweden
-
Veterans Medical Research FoundationEmory University; National Center for Complementary and Integrative Health... and other collaboratorsRecruitingPosttraumatic Stress DisorderUnited States
-
Toronto Metropolitan UniversityUniversity of British Columbia; Unity Health TorontoRecruitingHIV | Social Anxiety | Sexual RiskCanada
-
Uppsala UniversityKarolinska InstitutetCompleted